Free Cash Flow Chart

View Free Cash Flow for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 168.82M
March 31, 2026 186.43M
December 31, 2025 206.84M
September 30, 2025 192.11M
June 30, 2025 -62.77M
March 31, 2025 -130.64M
December 31, 2024 38.23M
September 30, 2024 40.53M
June 30, 2024 127.91M
March 31, 2024 148.78M
December 31, 2023 20.44M
September 30, 2023 -110.16M
June 30, 2023 -134.82M
March 31, 2023 -186.85M
December 31, 2022 -162.87M
September 30, 2022 -204.21M
June 30, 2022 -206.25M
March 31, 2022 -232.56M
December 31, 2021 -225.44M
September 30, 2021 -238.87M
June 30, 2021 -197.91M
March 31, 2021 -110.98M
December 31, 2020 -20.57M
September 30, 2020 -240.90M
June 30, 2020 -296.10M
Date Value
March 31, 2020 -364.37M
December 31, 2019 -441.77M
September 30, 2019 -97.10M
June 30, 2019 -79.09M
March 31, 2019 -62.14M
December 31, 2018 -79.22M
September 30, 2018 -100.67M
June 30, 2018 -108.61M
March 31, 2018 -40.89M
December 31, 2017 20.83M
September 30, 2017 145.19M
June 30, 2017 120.15M
March 31, 2017 61.76M
December 31, 2016 26.16M
September 30, 2016 -94.82M
June 30, 2016 -64.54M
March 31, 2016 -95.08M
December 31, 2015 6.750M
September 30, 2015 130.91M
June 30, 2015 126.04M
March 31, 2015 151.36M
December 31, 2014 41.42M
September 30, 2014 -34.45M
June 30, 2014 -49.11M
March 31, 2014 -0.1932M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Evaxion AS --
Genmab A/S 869.04M
Ascendis Pharma A/S 388.83M
Zealand Pharma A/S -253.76M
Agenus, Inc. -98.50M